Related by context. Frequent words. (Click for all words.) 61 Multicenter 61 placebo controlled clinical 61 ADHF 61 Acute Myocardial Infarction 60 Pivotal Trial 60 Thrombolysis 60 tumor lysis syndrome 60 stable angina 60 COPAXONE R 60 prospective observational 60 dronedarone 60 Enoxaparin 60 cardiovascular hospitalization 60 active comparator 60 PsA 59 thromboembolism 59 thromboembolic events 59 acute coronary syndromes ACS 59 Heart Failure Patients 59 T2DM 59 enalapril 59 multicentre 59 Lenalidomide 58 relapsed refractory multiple myeloma 58 Pivotal Phase III 58 Monotherapy 58 tolvaptan 58 bosentan 58 myocardial infarction stroke 58 Elderly Patients 58 Carotid 58 Rivaroxaban 58 double blinded placebo 58 lacosamide 57 J Am Coll 57 alpha blocker 57 Myocardial Infarction 57 tocilizumab 57 Torisel 57 plus methotrexate 57 Stenting 57 painful diabetic neuropathy 57 carotid artery stenting 57 Ischemic 57 ocular hypertension 57 Phase III Trial 57 Meta Analysis 57 Phase Ib clinical 57 #:#-# [031] 57 phase IIa 56 cerebrovascular events 56 Phase III Clinical Trial 56 acute myocardial infarction AMI 56 liver transplant recipients 56 dabigatran etexilate 56 Pharmacokinetic 56 noninferiority 56 Combination therapy 56 FOLFIRI 56 angiotensin converting enzyme inhibitors 56 Pioglitazone 56 HALTS 56 prospective randomized controlled 56 superficial bladder cancer 56 hypokalemia 56 secondary hyperparathyroidism 56 Asymptomatic 56 valvular heart 56 Coronary Stent 56 undergoing coronary artery 56 myocardial infarction MI 56 acute exacerbation 55 chemoradiotherapy 55 rosuvastatin 55 Drug Candidate 55 severe hypoglycemia 55 tiotropium 55 EORTC 55 Benign Prostatic Hyperplasia 55 PREVAIL 55 label multicenter 55 lupus nephritis 55 systemic embolism 55 vertebral fracture 55 Acute Coronary Syndrome 55 intracerebral hemorrhage 55 Arch Intern Med 55 glatiramer acetate 55 renal insufficiency 55 colectomy 55 fibrinolysis 55 Clinical Trial Results 55 placebo controlled clinical trials 55 #mg dose [003] 55 J Am Acad 55 multicenter randomized 55 ranolazine 55 adalimumab 55 % CI #.#-#.# [007] 55 Phase IIa trial 55 Phase 1b trial